人诱导多能干细胞来源心脏组织在模拟左心室辅助装置卸载的缺血模型中的治疗潜力
研究用大鼠异位心脏移植模型模拟心室辅助装置支持与心脏卸载,将人诱导多能干细胞来源心脏组织(HiCT)移植到心肌梗死心脏心外膜。结果显示卸载条件下HiCT植入率更高、梗死面积更小、血管密度增加,并抑制心肌细胞萎缩;作者认为该治疗可能有助于未来桥接恢复策略的进展。
要点
- 卸载条件下HiCT植入率83.3%(5/6只大鼠),植入面积大于负载条件(P < .05)。
- MI + HTx + HiCT组梗死面积显著小于MI组和MI + HTx组。
- HiCT抑制左心室卸载所致心肌细胞萎缩(P = .001),肌肉特异性RING finger 1蛋白水平低于MI + HTx组(P = .036)。
核心结论
- 在卸载条件下将HiCT移植到缺血心脏可促进植入、新生血管形成、减轻梗死重塑并抑制心肌细胞萎缩,结果提示HiCT治疗可能有助于未来桥接恢复策略的进展。
研究设计与样本
- 研究使用雄性无胸腺裸鼠行心肌梗死(MI),分为MI(负载、未治疗对照)、MI + HTx(卸载、未治疗对照)、MI + HTx + HiCT(卸载、治疗)和MI + HiCT(负载、治疗)四组。
- HiCT由人诱导多能干细胞来源心血管细胞制成的细胞片之间插入明胶水凝胶微球构建,治疗组将HiCT放置于心脏心外膜。
主要发现
- 4周后,MI + HTx + HiCT组6只大鼠中5只HiCT成功植入(83.3%)。
- 卸载条件(MI + HTx + HiCT)下植入的HiCT面积大于负载条件(MI + HiCT)(P < .05)。
- MI + HTx + HiCT组梗死面积显著小于MI组和MI + HTx组。
- MI + HTx + HiCT组边缘区血管密度大于MI组和MI + HTx组。
- HiCT治疗抑制了左心室卸载所致的心肌细胞萎缩(P = .001);MI + HTx + HiCT组肌肉特异性RING finger 1(一种萎缩相关泛素连接酶)蛋白水平低于MI + HTx组(P = .036)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to explore the therapeutic potential of human induced pluripotent stem cell (hiPSC)-derived cardiac tissues (HiCTs) in the emerging approach of bridge to recovery for severe heart failure with ventricular assist devices. We used a rat model of heterotopic heart transplantation (HTx) to mimic ventricular assist device support and heart unloading. METHODS: HiCTs were created by inserting gelatin hydrogel microspheres between cell sheets made from hiPSC-derived cardiovascular cells. Male athymic nude rats underwent myocardial infarction (MI) and were divided into the following groups: MI (loaded, untreated control), MI + HTx (unloaded, untreated control), MI + HTx + HiCT (unloaded, treated), and MI + HiCT (loaded, treated). HiCTs were placed on the epicardium of the heart in treated groups. We evaluated HiCT engraftment, fibrosis, and neovascularization using histologic analysis. RESULTS: After 4 weeks, HiCTs successfully engrafted in 5 of 6 rats in the MI + HTx + HiCT group (83.3%). The engrafted HiCT area was greater under unloaded conditions (MI + HTx + HiCT) than loaded conditions (MI + HiCT) (P < .05). MI + HTx + HiCT had a significantly smaller infarct area compared with MI and MI + HTx. The MI + HTx + MiCT group exhibited greater vascular density in the border zone than MI and MI + HTx. HiCT treatment suppressed cardiomyocyte atrophy due to left ventricular unloading (P = .001). The protein level of muscle-specific RING finger 1, an atrophy-related ubiquitin ligase, was lower in the MI + HTx + HiCT group than in MI + HTx (P = .036). CONCLUSIONS: Transplanting HiCTs into ischemic hearts under unloaded conditions promoted engraftment, neovascularization, attenuated infarct remodeling, and suppressed myocyte atrophy. These results suggest that HiCT treatment could contribute to future advancements in bridge to recovery.
引用
- Heima D, Takeda M, Tabata Y, et al. Therapeutic potential of human induced pluripotent stem cell-derived cardiac tissue in an ischemic model with unloaded condition mimicking left ventricular assist device. J Thorac Cardiovasc Surg. 2023. PMID: 37981100. doi:10.1016/j.jtcvs.2023.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。